| Autor: |
Şansal, Müfit, Üstüner, Mehmet Akif |
| Předmět: |
|
| Zdroj: |
Surgical Chronicles; Oct-Dec2023, Vol. 28 Issue 4, p359-362, 4p |
| Abstrakt: |
Objective: Pseudocyst is the most frequently observed cystic lesion of the pancreas and generally develops on the basis of pancreatitis. The aim of this study was to present cases of pancreas pseudocyst treated with endoscopic or surgical cystogastrostomy. Material and Method: A retrospective evaluation was made of patients who underwent an invasive procedure because of pancreas pseudocyst between January 2021 and June 2023. Results: The patients comprised 5 (55.5%) females and 4 (44.5%) males with a mean age of 50 years. The etiology of pseudocyst was observed to be biliary pancreatitis in 6 (66.6%) patients, postpartum pancreatitis in 2 (22.2%) patients, and pancreas head cancer in 1 (11.1%) patient. Cystogastrostomy was performed with placement of an endoscopic stent in 4 (44.5%) patients, laparotomy was performed in 3 (33.3%) patients when the endoscopic intervention failed, and direct surgical cystogastrostomy was performed in 2 (22.2%) patients. The mean time between pancreatitis and the invasive intervention was 115 days. The procedure was repeated in 4 (44.5%) patients applied with a stent and in 1 (11.1%) patient who underwent laparotomy. Change of stent was made in 2 patients applied with a stent. According to the Pan pancreas pseudocyst classification, all the patients were type 4. During a mean 7-month follow-up period, wound site infection was observed in 2 patients, and intra-abdominal abscess in 1. Conclusion: Cystogastrostomy with minimally invasive endoscopic drainage+stent can be used as the first option in the treatment of pancreas pseudocysts. When endoscopic interventions are not appropriate or not successful, conventional surgery can be safely selected. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
